10 October 2017
: Case report 
A Case of Diffuse Alveolar Hemorrhage as a Possible Complication of Bivalirudin Therapy
Unusual clinical course, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents
Htun Latt1ABCDEFG*, Sammy Aung2AEF, Kyaw Kyaw2AEF, Thein Tun Aung3EF, Chanwit Roongsritong2ABCDEFDOI: 10.12659/AJCR.905721
Am J Case Rep 2017; 18:1081-1085
Abstract
BACKGROUND: Diffuse alveolar hemorrhage (DAH) is a rare but potentially fatal complication of anticoagulant or antiplatelet therapy. Bivalirudin is a specific and reversible direct thrombin inhibitor (DTI).
CASE REPORT: We report a case of severe DAH, possibly related to bivalirudin use, in a 61-year-old patient undergoing coronary intervention. The patient had presented with an out-of-hospital cardiac arrest due to acute ST elevation myocardial infarction (STEMI). During the coronary intervention, shortly after receiving bivalirudin, the patient started having frank bleeding from the endotracheal tube and developed hemodynamic compromise. Despite aggressive intervention and intensive care, the patient died.
CONCLUSIONS: At this time, to our knowledge, there have been no reports of DAH associated with the use of bivalirudin.
Keywords: acute coronary syndrome, Hemorrhage, percutaneous coronary intervention
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.944088
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945135
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.944761
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.944980
Most Viewed Current Articles
21 Jun 2024 : Case report
58,722
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
42,753
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 
32,479
DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
23 Feb 2022 : Case report
20,016
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250